期刊文献+

西格列汀在糖尿病治疗中的药理作用及临床疗效观察 被引量:1

原文传递
导出
摘要 目的分析和研究西格列汀治疗糖尿病的药理作用和临床疗效。方法选取104例2型糖尿病患者分为两组,分别口服阿卡波糖和西格列汀治疗,观察两组治疗前后空腹、餐后2h静脉血糖变化和糖化血红蛋白变化。结果两组治疗3个月后空腹血糖、餐后2h血糖以及糖化血红蛋白水平均明显降低,观察组各项指标明显低于参照组,差异对比有统计学意义(P<0.05)。结论使用西格列汀治疗糖尿病具有良好的治疗效果,可有效降低患者血糖和糖化血红蛋白水平。
作者 柴辉
出处 《首都食品与医药》 2019年第2期49-49,共1页 Capital Food Medicine
  • 相关文献

参考文献4

二级参考文献37

  • 1Brubaker PL, Drucker DJ. Minireview: gIucagon-like peptdes regulate cell proliferation and apoptosis in the pancreas, gut and central nervous system. Endocrinology, 2004, 145: 2653-2659.
  • 2Baggio I.L, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology, 2007,132 : 2131 2157.
  • 3Cho YM, Kieffer TJ. K-cells and glucose-dependent insulino- tropic polypeptide in health and disease. Vitam Horm, 2010, 84:111q50.
  • 4Atkins D, Best D, griss PA, et al. Grading quality of evidence and strength of recommendations. BMJ, 2004,328 : 1490.
  • 5Aschner P, Kipnes MS, Lunceford JK, et al. Effect of the dipep tidyl peptidase-4 inhibitor sitagliptin as monotherapy on glyce mic control in patients with type 2 diabetes. Diabetes Care, 2006,29:2632 2637.
  • 6Russell Jones D, Cuddihy RM, Hanefeld M, et al. Efficacy and safety of exenatide once weekly versus metformin, pioglita- zone, and sitagliptin used as monotherapy in drug naive pa tients with type 2 diabetes(DURATION-4) :a 2g-week double- blind study. Diabetes Care, 2012,35 : 252 258.
  • 7Fonseea V, Staels B, Morgan JD, et al. Efficacy and safety of sitagliptin added to ongoing metformin and pioglitazone combi- nation therapy in a randomized, placebo controlled, 26-week trial in patients with type 2 diabetes. J Diabetes Complications, 2013,27 : 177-183.
  • 8Dobs AS,Goldstein BJ,Aschner P, et al. Efficacy and safety of sitagliptin added to ongoing metformin and rosiglitazone corn-bination therapy in a randomized placebo-controlled 54-week trial in patients with type 2 diabetes. J Diabetes, 2013, 5: 68-79.
  • 9Williams-Herman D, Johnson J, Teng R, et al. Efficacy and safety of sitagliptin and metformin as initial combination thera- py and as monotherapy over 2 years in patients with type 2 dia- betes. Diabetes Obes Meta, 2010,12 : 442-451.
  • 10Mohan V, Yang W,Son HY, eta[. Efficacy and safety of sita- gliptin in the treatment of patients with type 2 diabetes in Chi- na, India, and Korea. Diabetes Res Clin Pract, 2009, 83 106-116.

共引文献49

同被引文献9

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部